+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cure rates of oral contraceptive users and nonusers when treated for vulvo vaginal candidiasis moniliasis with miconazole nitrate 2 percent vaginal cream

Cure rates of oral contraceptive users and nonusers when treated for vulvo vaginal candidiasis moniliasis with miconazole nitrate 2 percent vaginal cream

Contraception 15(3): 355-362

There was no difference in the cure rates for vulvovaginal candidiasis [VC] in 261 oral contraceptive users and non-users treated with miconazole nitrate 2% vaginal cream (Monistat). A cure indicated a negative KOH smear, negative Nickerson's medium culture for Candida sp. and complete absence of the signs and symptoms of VC for 30 days following therapy. There is apparently no justification for routinely discontinuing oral contraceptive therapy during treatment for VC with Monistat.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 005075104

Download citation: RISBibTeXText

Related references

Cure rates of oral contraceptive users and non-users when treated for vulvovaginal candidiasis (moniliasis) with miconazole nitrate 2% vaginal cream. Contraception 15(3): 355-361, 1977

Efficacy of single dose 10 percent clotrimazole vaginal cream vs. fourteen days treatment with 2 percent miconazole vaginal cream in patients with vulvo vaginal candidosis. Archives of Gynecology 237(SUPPL): 179, 1985

Stability of cure in 72 cases of vulvo-vaginal candidiasis treated locally with miconazole (R 14,889. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1(5 Suppl 2): 372-374, 1972

Effect of butoconazole nitrate 2% vaginal cream and miconazole nitrate 2% vaginal cream treatments in patients with vulvovaginal candidiasis. Infectious Diseases in Obstetrics and Gynecology 4(6): 323-328, 1996

Clinical evaluation of econazole nitrate in 1 percent vaginal cream for treatment of vaginal candidiasis. European Journal of Obstetrics and Gynecology and Reproductive Biology 8(1): 5-8, 1978

A comparative double blind trial with vaginal creams of ciclopirox olamine and miconazole in vulvo vaginal candidiasis. Mykosen 24(12): 721-730, 1981

Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days. Journal of Women's Health and Gender-Based Medicine 9(4): 421-429, 2000

The effect of vaginal cream containing ginger in users of clotrimazole vaginal cream on vaginal candidiasis. Journal of Advanced Pharmaceutical Technology and Research 8(2): 80-84, 2017

Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group. Journal of Reproductive Medicine 44(11): 933-938, 1999

Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo. Journal of Reproductive Medicine 31(11): 1045-1048, 1986

A comparative study of miconazole nitrate pessaries and Nystan vaginal tablets in the treatment of vaginal candidiasis. British Journal of Clinical Practice 32(9): 258-259, 1978

Effects of coadministration of vaginal miconazole nitrate on the pharmacokinetics andabsorption of the nestorone and ethinyl estradiol contraceptive vaginal ring. Fertility and Sterility 108(3): E10-E11, 2017

Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis. Gynecologic and Obstetric Investigation 80(2): 113-118, 2016

Efficacy of various schedules of miconazole nitrate in vulvo-vaginal candidosis. Current Therapeutic Research 27(3): 323-328, 1980

Cure stability with miconazole in vaginal candidiasis. Acta Clinica Belgica 32(5): 291-296, 1977